Click on a filter below to refine your search. Remove a filter to broaden your search.
Lifestyle and risk factor modification was recognized as pillar of a-fib management for preventing onset, progression and adverse outcomes.
Solriamfetol was found to be well-tolerated with no significant effect on mean heart rate or systolic or diastolic blood pressure.
Even after adjusting for socioeconomic factors, environmental factors were independently tied to higher risk.